BioXcel Therapeutics, Inc. (BTAI) Ownership

$0.57

north_east
$0.16 (38.45%)
Day's range
$0.42
Day's range
$0.58

BioXcel Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARMISTICE CAPITAL, LLC 02/14/2025 4.32 M $1.61 M   100.00% 10.18%
UBS GROUP AG 02/14/2025 1.28 M $477,558   9,552.96% 3.01%
VANGUARD GROUP INC 02/11/2025 1.19 M $444,112   -1.16% 2.80%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 311,965 $116,667   4.67% 0.74%
MILLENNIUM MANAGEMENT LLC 02/14/2025 104,972 $39,249   -18.48% 0.25%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 77,900 $29,127   -40.02% 0.18%
SQUAREPOINT OPS LLC 02/14/2025 72,046 $26,938   203.86% 0.17%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 02/14/2025 38,050 $14,000   0.00% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 34,531 $12,911   0.95% 0.08%
HRT FINANCIAL LP 02/14/2025 25,505 $9,000   100.00% 0.06%
BLACKROCK FUNDING, INC. /DE 02/07/2025 380,608 $142,309   5.00% 0.06%
JANE STREET GROUP, LLC 02/14/2025 23,343 $8,728   -52.67% 0.06%
GROUP ONE TRADING, L.P. 02/14/2025 18,116 $6,774   -39.94% 0.04%
TWO SIGMA SECURITIES, LLC 02/14/2025 17,316 $6,474   100.00% 0.04%
POINT72 ASIA (SINGAPORE) PTE. LTD. 02/14/2025 15,939 $5,960   4.96% 0.04%
WELLS FARGO & COMPANY/MN 02/13/2025 199,010 $74,410   7.54% 0.03%
ENGINEERS GATE MANAGER LP 02/14/2025 11,985 $4,481   100.00% 0.03%
ADVISOR GROUP HOLDINGS, INC. 02/07/2025 8,500 $5,185   0.00% 0.02%
STATE STREET CORP 02/14/2025 77,149 $28,846   0.00% 0.01%
FEDERATED HERMES, INC. 02/13/2025 4,819 $1,802   0.00% 0.01%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 4,262 $1,594   100.00% 0.01%
ARETE WEALTH ADVISORS, LLC 02/12/2025 40,500 $15,000   0.00% 0.01%
DIVERSIFY WEALTH MANAGEMENT, LLC 01/16/2025 40,000 $15,092   0.00% 0.01%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/15/2025 39,368 $14,720   -1.82% 0.01%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 2,321 $868   -94.77% 0.01%
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) 02/07/2025 1,653 $618   -72.58% 0.00%
JPMORGAN CHASE & CO 02/12/2025 1,328 $496   77.30% 0.00%
VIRTU FINANCIAL LLC 02/11/2025 16,983 $6,000   100.00% 0.00%
02/06/2025 12,701 $4,749   100.00% 0.00%
DAVENPORT & CO LLC 01/24/2025 11,810 $4,416   -29.93% 0.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 02/10/2025 11,800 $4,412   -0.84% 0.00%
SEACREST WEALTH MANAGEMENT, LLC 01/14/2025 11,150 $4,169   -9.72% 0.00%
NEWEDGE ADVISORS, LLC 02/13/2025 500 $187   0.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 259 $97   -97.65% 0.00%
WASHINGTON TRUST ADVISORS, INC. 02/06/2025 2,572 $962   0.00% 0.00%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 02/14/2025 113 $42   0.00% 0.00%
PARKSIDE FINANCIAL BANK & TRUST 02/05/2025 1,800 $674   0.00% 0.00%
NATIONAL BANK OF CANADA /FI/ 02/12/2025 1,020 $381   -57.05% 0.00%
POINT72 (DIFC) LTD 02/14/2025 35 $13   12.90% 0.00%
US BANCORP \DE\ 02/05/2025 33 $12   -99.82% 0.00%
FARTHER FINANCE ADVISORS, LLC 02/10/2025 95 $36   100.00% 0.00%
TRUIST FINANCIAL CORP 01/31/2025 0 $0   -100.00% 0.00%
COMMONWEALTH EQUITY SERVICES, LLC 02/10/2025 0 $0   -100.00% 0.00%
CITIGROUP INC 02/12/2025 0 $0   -100.00% 0.00%
TOTH FINANCIAL ADVISORY CORP 01/21/2025 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 0 $0   -100.00% 0.00%
SIMPLEX TRADING, LLC 02/11/2025 0 $0   -100.00% 0.00%
ALLSQUARE WEALTH MANAGEMENT LLC 02/11/2025 0 $0   -100.00% 0.00%
APOLLON WEALTH MANAGEMENT, LLC 01/28/2025 0 $0   -100.00% 0.00%
XTX TOPCO LTD 02/13/2025 0 $0   -100.00% 0.00%

BioXcel Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 61 institutional investors and hedge funds held shares of BioXcel Therapeutics, Inc.. The most heavily invested institutionals were:

ARMISTICE CAPITAL, LLC: 4.32 M

UBS Group AG: 1.28 M

VANGUARD GROUP INC: 1.19 M

BlackRock Funding, Inc. /DE: 380,608

GEODE CAPITAL MANAGEMENT, LLC: 311,965

WELLS FARGO & COMPANY/MN: 199,010

1.26% of BioXcel Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 9.00 M shares in the last 24 months. This purchase volume represents approximately $5.13 M in transactions.